902 Shares in Intuitive Surgical, Inc. (NASDAQ:ISRG) Purchased by Yukon Wealth Management Inc.

Yukon Wealth Management Inc. bought a new position in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the SEC. The institutional investor bought 902 shares of the medical equipment provider's stock, valued at approximately $447,000.

Several other large investors have also made changes to their positions in ISRG. DAVENPORT & Co LLC raised its position in shares of Intuitive Surgical by 2.1% during the first quarter. DAVENPORT & Co LLC now owns 113,727 shares of the medical equipment provider's stock valued at $56,240,000 after buying an additional 2,302 shares during the last quarter. Summit Trail Advisors LLC grew its position in shares of Intuitive Surgical by 21.7% during the first quarter. Summit Trail Advisors LLC now owns 8,036 shares of the medical equipment provider's stock valued at $3,980,000 after purchasing an additional 1,434 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd boosted its stake in Intuitive Surgical by 3.3% during the first quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 60,161 shares of the medical equipment provider's stock valued at $29,796,000 after buying an additional 1,906 shares during the last quarter. Lansing Street Advisors increased its stake in Intuitive Surgical by 39.6% in the 1st quarter. Lansing Street Advisors now owns 818 shares of the medical equipment provider's stock worth $405,000 after acquiring an additional 232 shares during the last quarter. Finally, Vontobel Holding Ltd. grew its holdings in shares of Intuitive Surgical by 61.1% in the first quarter. Vontobel Holding Ltd. now owns 78,589 shares of the medical equipment provider's stock valued at $38,923,000 after purchasing an additional 29,813 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In related news, EVP Gary Loeb sold 1,700 shares of the company's stock in a transaction dated Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the transaction, the executive vice president owned 2,245 shares of the company's stock, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Robert Desantis sold 188 shares of the business's stock in a transaction that occurred on Monday, April 28th. The shares were sold at an average price of $515.91, for a total value of $96,991.08. Following the completion of the sale, the executive vice president owned 5,224 shares of the company's stock, valued at $2,695,113.84. This trade represents a 3.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts have recently issued reports on the stock. Robert W. Baird decreased their target price on shares of Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Citigroup reissued a "buy" rating and issued a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. Evercore ISI dropped their target price on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research report on Wednesday, April 23rd. Erste Group Bank raised Intuitive Surgical from a "hold" rating to a "buy" rating in a research note on Thursday, June 5th. Finally, Deutsche Bank Aktiengesellschaft downgraded Intuitive Surgical from a "hold" rating to a "sell" rating and cut their price objective for the company from $515.00 to $440.00 in a research report on Monday, June 9th. One research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average price target of $588.95.

Intuitive Surgical Stock Performance

Intuitive Surgical stock traded up $2.61 during mid-day trading on Wednesday, reaching $540.60. 1,487,420 shares of the company were exchanged, compared to its average volume of 1,668,652. Intuitive Surgical, Inc. has a 12-month low of $413.82 and a 12-month high of $616.00. The business has a fifty day moving average of $534.76 and a 200 day moving average of $536.73. The firm has a market cap of $193.76 billion, a P/E ratio of 79.27, a PEG ratio of 5.76 and a beta of 1.64.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Tuesday, April 22nd. The medical equipment provider reported $1.81 EPS for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.19 billion. During the same period last year, the firm posted $1.50 EPS. Sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.